Powered by

Actavis snaps up generics supplier Auden Mckenzie

Jan 27, 2015 - The Deal Pipeline
Mergers and Acquisitions

As it waits to close its landmark $66 billion purchase of Botox makerAllergan Inc. (AGN), Dublin pharmaceuticals company Actavis plc (ACT) has snapped up privately held U.K. generics maker Auden Mckenzie Holdings Ltd. for £306 million ($462 million).

Actavis said on Monday that the purchase will make it Britain's leading supplier of generic pharmaceuticals and will boost its non-GAAP earnings immediately. Actavis already markets more than 650 generics products in the U.K. and will ga...